Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses

Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses

Chromothripsis is a catastrophic event involving numerous chromosomal rearrangements in confined genomic regions of one or a few chromosomes, causing complex effects on cells via the extensive structural variation. The development of whole-genome sequencing (WGS) has promoted great progress in explo...

Full description

Bibliographic Details
Main Authors:	Qin Zhang, Lujie Yang, He Xiao, Zhaoqian Dang, Xunjie Kuang, Yanli Xiong, Jianwu Zhu, Zhou Huang, Mengxia Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Oncology
Subjects:	chromothripsis tumor immunity drug resistance prognosis immune checkpoint inhibitors therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1074955/full

Similar Items

Research progress on chromothripsis and tumorigenesis
by: MENG Huanliang, MU Haoran, JIANG Yafei, TIAN Kai, HE Enjun, HUA Yingqi
Published: (2023-04-01)

Chromothripsis in Treatment Resistance in Multiple Myeloma
by: Kyoung Joo Lee, et al.
Published: (2017-09-01)

Chromothripsis—Explosion in Genetic Science
by: Mariia Shorokhova, et al.
Published: (2021-05-01)

Micronuclei-based model system reveals functional consequences of chromothripsis in human cells
by: Maja Kneissig, et al.
Published: (2019-11-01)

Insight into the Molecular Basis Underlying Chromothripsis
by: Katarzyna Ostapińska, et al.
Published: (2022-03-01)

On the Complexity of Mechanisms and Consequences of Chromothripsis: An Update
by: Alla S. Koltsova, et al.
Published: (2019-04-01)

Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse
by: Jan Smetana, et al.
Published: (2018-01-01)

Chromothripsis in lipoblastoma: second reported case with complex PLAG1 rearrangement
by: Joel Lanceta, et al.
Published: (2023-11-01)

Pediatric spinal ependymoma with chromothripsis of chromosome 6: a case report and review of the literature
by: Keela R. Scott, et al.
Published: (2024-02-01)

Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia with Chromothripsis in an Old Woman
by: Li Tan, et al.
Published: (2015-01-01)

Chromosomal Rearrangements and Chromothripsis: The Alternative End Generation Model
by: Daniel de Groot, et al.
Published: (2023-01-01)

Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability
by: Kristyna Zavacka, et al.
Published: (2021-11-01)

Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy
by: Ya-Dong Li, et al.
Published: (2023-08-01)

Long-read sequencing reveals chromothripsis in a molecularly unsolved case of Cornelia de Lange syndrome
by: Ilaria Bestetti, et al.
Published: (2024-03-01)

Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
by: Tao Jiang, et al.
Published: (2020-06-01)

Identification of HSP90B1 in pan-cancer hallmarks to aid development of a potential therapeutic target
by: Xiaoliang Huang, et al.
Published: (2024-01-01)

A human pan-cancer system analysis of regulator of chromatin condensation 2
by: Siming Gong, et al.
Published: (2023-02-01)

Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
by: Xiashuang Zhao, et al.
Published: (2023-02-01)

bMSAF is a prognostic predictor for advanced hepatocellular carcinoma patients treated with immune checkpoint inhibitor camrelizumab and anti‐angiogenic agent apatinib combination therapy
by: Gehan Xu, et al.
Published: (2022-10-01)

Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma
by: Jinna Li, et al.
Published: (2023-08-01)

Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma
by: Genhao Zhang, et al.
Published: (2022-08-01)

Chromosome Changes in Soma and Germ Line: Heritability and Evolutionary Outcome
by: Irina Bakloushinskaya
Published: (2022-03-01)

Mosaic proximal trisomy 13q and regular trisomy 13 in a female patient with long survival: Involvement of an incomplete trisomic rescue and a chromothripsis event
by: Verónica Fabiola Morán‐Barroso, et al.
Published: (2021-09-01)

Pan-Cancer Analysis Identifies Liver Metastases as Negative Predictive Factor for Immune Checkpoint Inhibitors Treatment Outcome
by: Xiao-Juan Chen, et al.
Published: (2021-06-01)

Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas
by: Siliang Chen, et al.
Published: (2022-11-01)

Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer
by: Zhao-Cong Zhang, et al.
Published: (2021-11-01)

Impact of Immune-Related Adverse Events on Immune Checkpoint Inhibitors Treated Cancer Patients’ Survival: Single Center Experience and Literature Review
by: Raquel Romão, et al.
Published: (2023-01-01)

Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma
by: Shuxin Zhang, et al.
Published: (2022-11-01)

Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
by: Susu Zheng, et al.
Published: (2021-12-01)

TRIM56: a promising prognostic immune biomarker for glioma revealed by pan-cancer and single-cell analysis
by: Bingcheng Wang, et al.
Published: (2024-01-01)

An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer
by: Fengyun Cong, et al.
Published: (2022-08-01)

Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes
by: Jia-Tong Ding, et al.
Published: (2023-01-01)

ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer
by: Chun-Lin Lin, et al.
Published: (2020-05-01)

Interphase Cytogenetic Analysis of Micronucleated and Multinucleated Cells Supports the Premature Chromosome Condensation Hypothesis as the Mechanistic Origin of Chromothripsis
by: Antonio Pantelias, et al.
Published: (2019-08-01)

The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy
by: Haokang Feng, et al.
Published: (2024-01-01)

MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
by: Yong Zhou, et al.
Published: (2022-10-01)

<i>TP53</i> Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype
by: Silvia Ramos-Campoy, et al.
Published: (2022-07-01)

Prognostic and immunological role of SERPINH1 in pan-cancer
by: Huage Zhong, et al.
Published: (2022-08-01)

A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning
by: Maurizio Polano, et al.
Published: (2019-10-01)

Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer
by: Yanmeizhi Wu, et al.
Published: (2022-09-01)